XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net (loss) income $ (120,797) $ 102,743
Adjustments to reconcile net (loss) income to net cash provided by operating activities:    
Depreciation and amortization 164,027 124,749
Impairment expense 188,601 0
Deferred income tax (benefit) expense (29,224) 28,753
Amortization of deferred debt issuance costs 327 250
Stock-based compensation 12,975 10,604
Loss on disposal of assets 11,884 62,117
Unrealized loss on short-term investment 340 2,120
Noncash gain from adjustment of business acquisition contingent consideration (1,800) 0
Changes in operating assets and liabilities, net of effects of business acquisition:    
Accounts receivable 21,876 (44,832)
Other current assets (480) (2,584)
Inventories 962 (4,520)
Prepaid expenses 4,966 (275)
Accounts payable (31,933) 9,584
Accrued and other current liabilities (7,292) 16,362
Net cash provided by operating activities 214,432 305,071
CASH FLOWS FROM INVESTING ACTIVITIES:    
Capital expenditures (112,449) (320,747)
Business acquisition, net of cash acquired (21,038) 0
Proceeds from sale of assets 2,884 7,976
Net cash used in investing activities (130,603) (312,771)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from borrowings 0 30,000
Repayments of borrowings 0 (15,000)
Payment of debt issuance costs 0 (1,179)
Payments on finance lease obligations (13,067) (889)
Tax withholdings paid for net settlement of equity awards (1,377) (3,506)
Share repurchases (55,729) (36,258)
Payment of excise tax on share repurchases (444) 0
Net cash used in financing activities (70,617) (26,832)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS 13,212 (34,532)
CASH AND CASH EQUIVALENTS - Beginning of period 33,354 88,862
CASH AND CASH EQUIVALENTS - End of period 46,566 54,330
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:    
Capital expenditures included in accounts payable and accrued liabilities 17,779 33,189
Business acquisition deferred cash consideration included in other current liabilities 3,664 0
Business acquisition contingent consideration included in other long-term liabilities $ 10,900 $ 0